Search

Home > New England Journal of Medicine Interviews > NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
Podcast: New England Journal of Medicine Interviews
Episode:

NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
Category: Religion & Spirituality
Duration: 00:09:57
Publish Date: 2025-12-10 15:01:00
Description: Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.
Total Play: 0

Users also like

1K+ Episodes
医学講座 400+     50+
400+ Episodes
NEJM This We .. 90+     10+

Some more Podcasts by NEJM Group

400+ Episodes
NEJM This We .. 90+     10+
100+ Episodes
Clinical Con .. 10+     4
70+ Episodes
NEJM Residen ..    
900+ Episodes
NEJM Intervi ..